Novavax
NVAX
NVAX
426 hedge funds and large institutions have $4.8B invested in Novavax in 2021 Q4 according to their latest regulatory filings, with 80 funds opening new positions, 136 increasing their positions, 154 reducing their positions, and 88 closing their positions.
New
Increased
Maintained
Reduced
Closed
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
38% less capital invested
Capital invested by funds: $7.76B → $4.8B (-$2.95B)
44% less call options, than puts
Call options by funds: $1.21B | Put options by funds: $2.18B
83% less funds holding in top 10
Funds holding in top 10: 6 → 1 (-5)
Holders
426
Holding in Top 10
1
Calls
$1.21B
Puts
$2.18B
Top Buyers
| 1 | +$169M | |
| 2 | +$65.6M | |
| 3 | +$46.5M | |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
+$39.9M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$33.4M |
Top Sellers
| 1 | -$217M | |
| 2 | -$129M | |
| 3 | -$104M | |
| 4 |
BlackRock
New York
|
-$91.3M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$79.7M |